Ensayos clínicos de Obesidad en Illinois
55 estudios sobre Obesidad buscan participantes en Illinois.
Ciudades en Illinois
- Chicago40 estudios
- Evanston10 estudios
- Cicero4 estudios
- Arlington Heights4 estudios
- Champaign4 estudios
- Waukegan3 estudios
Texto oficial del estudio (inglés)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Alliance For Multispecialty Research - Oak Brook, Oak Brook
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Elevate Clinical Research, Gurnee
- Knownwell, Schaumburg
- Endeavor Health, Skokie
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Central Illinois Diabetes and Clinical Research, Springfield
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
- Northwestern University-Feinberg School of Medicine, Chicago
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT05687604Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Charter Research LLC - Chicago, Chicago
- Flourish Research, Ravenswood Rheumatology, Chicago
- AMR Clinical - Chicago Oak Brook, Oak Brook
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Endeavor Health, Skokie
- Central Illinois Diabetes and Clinical Research, a Division of Prairie Education and Research Cooper, Springfield
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Northwestern Medicine, Chicago
- Northwestern Memorial Hospital, Diagnostic Testing Center (Phlebotomy/EKG), Chicago
- Northwestern Memorial Hospital, Investigational Drug Service, Chicago
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07919678A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07595549Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Ann and Robert H Lurie Children's Hospital of Chicago, Chicago
- University of Illinois at Chicago, Chicago
ReclutandoFase 3
Edades de 6 a 11 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NorthShore University Health System, Skokie
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Great Lakes Clinical Trials - Ravenswood, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Rush University Medical Center, Chicago
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Ann and Robert Lurie Children's Hospital of Chicago, Chicago
- University of Illinois at Chicago, Chicago
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Accellacare - DuPage, Lombard
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Chicago Medical Research LLC, Hazel Crest
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Chicago
- Research Site, Melrose Park
- Research Site, Oak Brook
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Christie Clinic, Champaign
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07837973A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 7 oct 2026 · NCT06143956AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Chicago Research Center, Inc, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Flourish Research - Great Lakes Clinical Trials, Chicago
- Endeavor Health, Skokie
- Evanston Premier Healthcare Research LLC, Skokie
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)
- Biofortis Clinical Research, Addison
- Illinois Institute of Technology, Chicago
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 69 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07789769Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Endeavor Health, Skokie
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684144AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Great Lakes Clinical Trials, Chicago
- Clinical Investigation Spec Gurnee, Gurnee
- Endeavor Health, Skokie
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Chicago Research Center, Inc, Chicago
- Endeavor Health, Skokie
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07668414AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Endeavor Health, Skokie
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07339423A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Schaumburg
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Schaumburg
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743463AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- University Of Chicago, Chicago
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07571005A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Walgreens - Store 11760, Oak Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07745504BRIDGE & Friends Trial
- University of Illinois Chicago, Chicago
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 79 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07798557Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
- Illinois Institute of Technology, Chicago
ReclutandoSe aceptan voluntarios sanos
Edades de 21 a 74 · Todos los sexos · Actualizado el 27 ago 2026 · NCT07566325Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
ReclutandoFase 2
Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older
- Department of Medicine, Vitoux Program on Aging and Prevention, Chicago
Reclutando
Edades de 50 a 74 · Todos los sexos · Actualizado el 18 ago 2026 · NCT06636058A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Chicago Clinical Research Institute INC, Chicago
- Univer Of Illinois at Chicago, Chicago
- Eagle Clinical Research, Chicago
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.